Foundation of Sleep and Health Science Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2018
NCT03461042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Yoyoghi Sleep Disorder Clinic / Foundation of Sleep and Health Science | Yoyogi Sleep Disorder Clinic, Foundation of Sleep and Health Science

Active Ingredients

Drugs in Phase 4 Trials (1)

ramelteon (rozerem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1